ImageneBio, Inc.
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
ImageneBio, Inc. (IMA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.191x
Based on the latest financial reports, ImageneBio, Inc. (IMA) has a cash flow conversion efficiency ratio of -0.191x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-26.64 Million) by net assets ($139.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ImageneBio, Inc. - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how ImageneBio, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ImageneBio, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ImageneBio, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
T.K.S. Technologies Public Company Limited
BK:TKS
|
0.027x |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
|
0.036x |
|
Tembo Global Industries Limited
NSE:TEMBO
|
0.005x |
|
Saksiam Leasing Public Company Limited
BK:SAK
|
0.184x |
|
Cameo Communications Inc
TW:6142
|
-0.032x |
|
ReaLy Development & Construction
TWO:2596
|
-0.097x |
|
SOLTEC POWER HOLD. EO-25
F:5PZ
|
N/A |
|
Marie Brizard Wine & Spirits
PA:MBWS
|
0.003x |
Annual Cash Flow Conversion Efficiency for ImageneBio, Inc. (2018–2024)
The table below shows the annual cash flow conversion efficiency of ImageneBio, Inc. from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $125.93 Million | $-46.00 Million | -0.365x | +22.23% |
| 2023-12-31 | $169.76 Million | $-79.74 Million | -0.470x | +6.84% |
| 2022-12-31 | $146.97 Million | $-74.11 Million | -0.504x | -73.97% |
| 2021-12-31 | $207.88 Million | $-60.25 Million | -0.290x | -177.43% |
| 2020-12-31 | $-101.05 Million | $-37.83 Million | 0.374x | +148.01% |
| 2019-12-31 | $-61.46 Million | $47.93 Million | -0.780x | -407.93% |
| 2018-12-31 | $-45.84 Million | $-11.61 Million | 0.253x | -- |